ALS Ltd
ALQ: XASX (AUS)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|.Vt | LOCK|&>b%? | LOCK|zt>#B>f |
ALS Limited Earnings: Profit Target Missed, and a Steadying Equity Raise
Materials testing specialist ALS posted a 1% decline in underlying fiscal 2025 net profit after tax to AUD 293 million. It will raise up to AUD 390 million in a fully underwritten placement and share purchase plan to upgrade four major hub laboratories and maintain balance sheet flexibility.
